Author
Listed:
- Sabrina M. Bedell
(Department of Women’s Health, Obstetrics and Gynecology, University of Minnesota, Minneapolis, MN 55454, USA
Division of Gynecologic Oncology, Women’s Health Institute, Cleveland Clinic Foundation, Cleveland, OH 44106, USA)
- Grace R. Lyden
(Division of Biostatistics, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA)
- Sheela Sathyanarayana
(Department of Pediatrics, Environmental and Occupational Health Sciences, University of Washington, Seattle, WA 98145, USA
Seattle Children’s Research Institute, Seattle, WA 98121, USA)
- Emily S. Barrett
(Department of Biostatistics and Epidemiology, Rutgers School of Public Health and Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ 08854, USA)
- Kelly K. Ferguson
(Epidemiology Branch, National Institute of Environmental Health Sciences, Durham, NC 27709, USA)
- Ashley Santilli
(Department of Neurology, Mayo Clinic, Rochester, MN 55904, USA)
- Nicole R. Bush
(Departments of Psychiatry and Behavioral Sciences and of Pediatrics, University of California at San Francisco, San Francisco, CA 94143, USA)
- Shanna H. Swan
(Department of Preventive Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA)
- Thomas F. McElrath
(Department of Epidemiology, Harvard T.H. Chan School of Public Health, Division of Maternal-Fetal Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA)
- Ruby H.N. Nguyen
(Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, MN 55454, USA)
Abstract
The purpose of this study was to determine whether maternal urinary phthalate metabolite concentrations are associated with the development of higher blood pressure or pregnancy-induced hypertension (PIH). Participants were women without chronic hypertension who enrolled in The Infant Development and the Environment Study, a prospective pregnancy cohort conducted at four U.S. academic medical centers from 2010–2012. Prenatal records were reviewed to obtain blood pressure measurements and diagnoses of PIH (gestational hypertension, preeclampsia, eclampsia, and HELLP syndrome, defined as hemolysis, elevated liver enzymes, and low platelet count). Complete-case analyses used multivariable linear and logistic regression for analysis of blood pressure measurements and PIH diagnoses, respectively. In the final dataset (N = 668), higher concentrations of first-trimester monoethyl phthalate (MEP) and mono-3-carboxypropyl phthalate (MCPP) and third-trimester mono-isobutyl phthalate (MiBP) were significantly associated with a medical chart diagnosis of PIH. First-trimester mono-n-butyl phthalate (MBP) and MEP along with the sum of di-(2-ethylhexyl) phthalate metabolites (∑DEHP) were each associated with increased systolic blood pressure across pregnancy. In conclusion, several phthalate metabolite concentrations were significantly associated with PIH and greater increases in systolic blood pressure across pregnancy.
Suggested Citation
Sabrina M. Bedell & Grace R. Lyden & Sheela Sathyanarayana & Emily S. Barrett & Kelly K. Ferguson & Ashley Santilli & Nicole R. Bush & Shanna H. Swan & Thomas F. McElrath & Ruby H.N. Nguyen, 2021.
"First- and Third-Trimester Urinary Phthalate Metabolites in the Development of Hypertensive Diseases of Pregnancy,"
IJERPH, MDPI, vol. 18(20), pages 1-13, October.
Handle:
RePEc:gam:jijerp:v:18:y:2021:i:20:p:10627-:d:653366
Download full text from publisher
References listed on IDEAS
- Ivy Shiue, 2014.
"Higher Urinary Heavy Metal, Phthalate, and Arsenic but Not Parabens Concentrations in People with High Blood Pressure, U.S. NHANES, 2011–2012,"
IJERPH, MDPI, vol. 11(6), pages 1-11, June.
Full references (including those not matched with items on IDEAS)
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:18:y:2021:i:20:p:10627-:d:653366. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.